A low white cell count that may be Duffy-null (neutrophil count)
Why is my white blood cell count low?
The answer
Many people of African ancestry are Duffy-null, an inherited blood-cell variant that gives a lower neutrophil count (the white cells that fight infection). The main study calls it clinically insignificant. The risk is being misread: a normal count for you can be flagged as low.
What it is
- An inherited variant: red cells do not carry the Duffy antigen. Common in people of African descent.Tested Merz 2023
- Not a disease: it gives a lower neutrophil count without raising infection risk.Tested Hibbs 2025
How to find out if you have it
- A blood test (Duffy testing), done with a full blood count in the main study.Tested Merz 2023
- A haematology review urges clinicians to use Duffy-null reference ranges, so ask your doctor or a haematologist whether yours applies, especially if your count is low and you are well.Tested Hibbs 2025
What it changes for you
- Your neutrophil count runs lower than other people: median 2,820 against 5,005 per microlitre in one clinic.Tested Merz 2023
- Many cancer trials exclude people whose count is in the Duffy-null range.Tested Hibbs 2024
- Standard cut-offs can wrongly label you neutropenic, which can affect treatment and dosing decisions.Tested Hibbs 2025
What it does not change
- It does not raise your risk of infection.Tested Hibbs 2025
- It is not a disease and needs no treatment on its own.Tested Merz 2023
What families do
Tradition and common belief, not evidence.
Nothing is passed down about this; it is a blood-test result, usually met in a clinic. Many Black people have been told a low count is 'normal for your race' or a worry, without the reason being explained.
The evidence
Many people of African ancestry are Duffy-null: in one US clinic two-thirds of 120 healthy Black adults were. Duffy-null people have lower neutrophil counts than other people, and the authors of that study call the difference clinically insignificant. Ask your doctor whether Duffy-null explains a low count before anyone treats it or excludes you from a trial.
This tier rests on: That Duffy-null lowers the neutrophil count without disease: a clinic study of 120, genetic data on 6,005, and a review.
Why this tier and strength: Observational and genetic data in Black populations (n=120 and n=6,005) plus a bibliometric count of trial exclusions; it would move to A if a trial tested outcomes using Duffy-specific cut-offs.
What has been tested
B 120 healthy self-identified Black and African American adults at one US primary care centre (n=120)
Cross-sectional comparison of neutrophil counts by Duffy phenotype, with Duffy testing.
66.7% (80 of 120) were Duffy-null. Median absolute neutrophil count was 2,820 cells per microlitre in Duffy-null people against 5,005 in Duffy non-null (P<.001). 23.8% (19 of 80) of Duffy-null people had a count below 2,000, against none of the non-null. The authors state the Duffy-null phenotype is clinically insignificant and advocate Duffy-null-specific reference ranges.
Merz LE, Story CM, Osei MA, Jolley K et al (2023), Blood Advances, [primary] Open source Study page
Note: Single centre, n=120; whether the 'clinically insignificant' conclusion holds for all settings is the authors' claim.
B 6,005 African Americans from three cohort studies (n=6005)
Genetic association analysis.
The Duffy Null variant (rs2814778) predicted white cell and neutrophil count in African Americans beyond the previously described admixture association, establishing a new phenotype for the variant.
Reich D, Nalls MA, Kao WH, Akylbekova EL et al (2009), PLoS Genetics, [primary] Open source Study page
B Phase 3 cancer trials for prostate, breast, melanoma, colorectal and lung cancers, 2021-2023 (n=382)
Cross-sectional analysis of trial exclusion criteria and chemotherapy dose-modification rules.
Of 289 eligible trials, 221 (76.5%, 95% CI 71.1-81.2) excluded patients whose neutrophil counts were within the Duffy-null reference range. Colorectal trials had the highest exclusion proportion (86.4%), prostate the lowest (47.8%).
Hibbs SP, Aiken L, Vora K, Mowete C et al (2024), JAMA Network Open, [bibliometric] Open source Study page
B Narrative review (n=not stated)
Review of Duffy antigen testing, epidemiology, neutrophil counts and clinical consequences.
The Duffy null variant is a non-pathological mutation that is partly protective against Plasmodium vivax and gives a lower neutrophil count without increasing infection risk. In many regions neutropenia has been defined by the counts of Duffy-positive people, which may be unsuitable for decisions in Duffy-null people.
Hibbs SP, Jones J, Hantel A, Merz LE (2025), British Journal of Haematology, [review] Open source Study page
B Duffy-null Black people and dose decisions (n=0)
Search for trial evidence that Duffy-specific reference ranges are safe.
I found papers on febrile neutropenia in Duffy-null patients with myeloma (Abdallah 2024, abstract not retrievable) and on CDK4/6 inhibitors in breast cancer (Ferri 2025, not opened). I could not confirm trial evidence for safe use of Duffy-specific thresholds. UNVERIFIED.
Abdallah M, Arters F, Patel J, Edwards C et al (2024), Blood Advances, [primary] Open source Study page
Note: Title only seen in search; the abstract returned empty from PubMed.
Harm
Signal: The harm is from misreading, not from the variant: 76.5% of 289 recent phase 3 cancer trials excluded neutrophil counts within the Duffy-null range (Hibbs 2024), and a count under 2,000 was found in 24% of Duffy-null healthy adults (Merz 2023), so people can be wrongly treated as unwell or turned away.
Measured variables
- Duffy phenotype or genotype (rs2814778), a blood test
- Absolute neutrophil count
- Self-identified race is a stand-in; Duffy-null also occurs in people of Middle Eastern ancestry (Hibbs 2024 abstract)
Not tested, and gaps
Untested in trials: outcomes (infection, treatment tolerance) when Duffy-null-specific thresholds are used; how often NHS or other labs report Duffy-adjusted ranges. Not verified: the claim of 65% US and 80% UK prevalence (12 Nov research file, via Tsiamita 2025, not opened by me). Duffy testing availability for patients is unverified.
All sources
Common questions
Why is my white blood cell count low?
Many people of African ancestry are Duffy-null, an inherited blood-cell variant that gives a lower neutrophil count (the white cells that fight infection).
What is benign ethnic neutropenia?
Many people of African ancestry are Duffy-null, an inherited blood-cell variant that gives a lower neutrophil count (the white cells that fight infection).
Is a low neutrophil count normal for Black people?
The risk is being misread: a normal count for you can be flagged as low.
Why was I turned away from a clinical trial for a low neutrophil count?
The risk is being misread: a normal count for you can be flagged as low.
Last checked against its sources: . Next check due: 12 May 2027.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence.